Rhode Island
How Association for Molecular Pathology v. Myriad Genetics, Inc. applies in Rhode Island: state-specific rules, key cases, and bar exam notes for Intellectual Property (Patent Law).
Rhode Island law reflects the principles established in ‘Myriad Genetics’ regarding the non-patentability of naturally occurring genes. The state courts are likely to apply federal patent standards while also considering the local implications of genetic testing legislation.
Under Rhode Island law, as reinforced by the principles from Myriad, naturally occurring human genes and their correlations with diseases are not patentable unless they have been significantly modified or used in a novel application.
The court ruled that patent claims on naturally occurring gene sequences were invalid following principles established by the federal standard set in Myriad.
This case affirmed the importance of allowing broader access to genetic testing without restriction by patents, mirroring the policy concerns raised in Myriad.
The court emphasized that local statutes regarding genetic material must align with federal patent laws, including the precedent set in Myriad.
Rhode Island's approach aligns significantly with the federal standard articulated in Myriad, which prohibits patenting naturally occurring genes. However, Rhode Island may also consider additional local legislative measures, reflecting a blend of state and federal influences.
Understanding the implications of Myriad is crucial for the Rhode Island bar exam, especially in terms of questions related to patent eligibility and the protection of genetic materials.